Pharmacological characterisation of novel kinin B2 receptor ligands

被引：2

作者：

Camarda, V

Rizzi, A

Calò, G

Wirth, K

Regoli, D ^{[1
]}

机构：

[1] Univ Ferrara, Dept Expt & Clin Med, Pharmacol Sect, I-44100 Ferrara, Italy

[2] Aventis Pharma, Cardiovasc Dis Grp, Frankfurt, Germany

来源：

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2002年 / 80卷 / 04期

关键词：

bradykinin; B-2 receptor ligands; bioassay; isolated vessels;

D O I：

10.1139/Y02-037

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Peptide and nonpeptide compounds have been shown to interact specifically with B-2 receptors of three different species, namely human, rabbit, and pig. Peptide agonists and nonpeptide antagonists show marked differences in potencies and suggest the existence of B-2 receptor subtypes. This conclusion is based on data obtained with the modified agonist peptide LF 150943 whose potency (pEC(50) 9.4) is at least 100-fold higher in rabbit than in humans (7.4) and pig (6.7). The same conclusion can be drawn from data obtained with antagonists that are more potent in humans (LF 160687, pA(2) 9.2) than in rabbit (8.7) and pig (8.2) or with antagonists (S 1567) that show the opposite potency order, being much weaker in humans (pA(2) 6.9) than in rabbit (7.6) and pig (9.4). Two other compounds (FR 173657 and FR 172357) show similar pharmacological spectra as S 1567 and differ from LF 160687.

引用

页码：281 / 286

页数：6

共 50 条

[41] Kinin-Stimulated B1 Receptor Signaling Depends on Receptor Endocytosis Whereas B2 Receptor Signaling Does Not
Enquist, Johan
Sanden, Caroline
Skroder, Carl
Mathis, Sandra A.
Leeb-Lundberg, L. M. Fredrik
NEUROCHEMICAL RESEARCH, 2014, 39 (06) : 1037 - 1047
[42] Kinin-Stimulated B1 Receptor Signaling Depends on Receptor Endocytosis Whereas B2 Receptor Signaling Does Not
Johan Enquist
Caroline Sandén
Carl Skröder
Sandra A. Mathis
L. M. Fredrik Leeb-Lundberg
Neurochemical Research, 2014, 39 : 1037 - 1047
[43] Bifunctional epitope-agonist ligands of the bradykinin B2 receptor
Gera, Lajos
Roy, Caroline
Marceau, Francois
BIOLOGICAL CHEMISTRY, 2013, 394 (03) : 379 - 383
[44] Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African Americans
Gainer, J
Brown, N
Bachvarova, M
Bastien, L
Maltais, I
Marceau, F
Bachvarov, D
JOURNAL OF HYPERTENSION, 2000, 18 : S174 - S174
[45] In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN11270
Meini, S
Lecci, A
Carini, F
Tramontana, M
Giuliani, S
Maggi, CA
Ricci, R
Fabbri, G
Anichini, B
Harmat, N
Rizzi, A
Camarda, V
Regoli, D
Quartara, L
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (04) : 293 - 302
[46] Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice
Ferreira, J
da Silva, GL
Calixto, JB
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (05) : 787 - 794
[47] Effect of kinin B2 receptor ablation on skeletal muscle development and myostatin gene expression
Souza, K. de Picoli
Batista, E. C.
Silva, E. D.
Reis, F. C.
Silva, S. M. A.
Araujo, R. C.
Luz, J.
Santos, E. L.
Pesquero, J. B.
NEUROPEPTIDES, 2010, 44 (02) : 209 - 214
[48] Hippocampal expression of kinin B2 receptor in female rats submitted to the pilocarpine model of epilepsy
Argañaraz, GA
Perosa, SR
Carvalho, FF
Silva, JA
Cavalheiro, EA
Amado, D
Naffah-Mazzacoratti, MG
EPILEPSIA, 2005, 46 : 371 - 371
[49] Inhibition of kinin breakdown prolongs retention and action of bradykinin in a myocardial B2 receptor compartment
Dendorfer, A
Folkers, V
Klinger, M
Wolfrum, S
Dominiak, P
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (02) : 310 - 316
[50] Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice
Trabold, F
Pons, S
Hagege, AA
Bloch-Faure, M
Alhenc-Gelas, F
Giudicelli, JF
Richer-Giudicelli, C
Meneton, P
HYPERTENSION, 2002, 40 (01) : 90 - 95

← 1 2 3 4 5 →